Open Access Helper

OpenAlex Citation Counts

OpenAlex Citations Logo

OpenAlex is a bibliographic catalogue of scientific papers, authors and institutions accessible in open access mode, named after the Library of Alexandria. It's citation coverage is excellent and I hope you will find utility in this listing of citing articles!

If you click the article title, you'll navigate to the article, as listed in CrossRef. If you click the Open Access links, you'll navigate to the "best Open Access location". Clicking the citation count will open this listing for that article. Lastly at the bottom of the page, you'll find basic pagination options.

Requested Article:

Tocilizumab attenuates acute lung and kidney injuries and improves survival in a rat model of sepsis via down-regulation of NF-κB/JNK: a possible role of P-glycoprotein
Yasmine Ibrahim, Rabab A. Moussa, Asmaa M. A. Bayoumi, et al.
Inflammopharmacology (2019) Vol. 28, Iss. 1, pp. 215-230
Closed Access | Times Cited: 60

Showing 26-50 of 60 citing articles:

Angiotensin aldosterone inhibitors improve survival and ameliorate kidney injury induced by sepsis through suppression of inflammation and apoptosis
Alaa Al‐Kadi, Mahmoud El‐Daly, Nashwa Fathy Gamal El‐Tahawy, et al.
Fundamental and Clinical Pharmacology (2021) Vol. 36, Iss. 2, pp. 286-295
Closed Access | Times Cited: 16
Interleukin-6 inhibitors in non-COVID-19 ARDS: analyzing the past to step into the post-COVID-19 era
Lucia Gandini, Gabriele Fior, Andreas Schibler, et al.
Critical Care (2023) Vol. 27, Iss. 1
Open Access | Times Cited: 6
Madecassoside alleviates acute kidney injury by regulating JNK-mediated oxidative stress and programmed cell death
Run-run Shan, Ju-tao Yu, Shaofei Zhang, et al.
Phytomedicine (2023) Vol. 123, pp. 155252-155252
Closed Access | Times Cited: 6
Recent Updates in Experimental Research and Clinical Evaluation on Drugs for COVID-19 Treatment
Houwen Zou, Yuqi Yang, Huiqiang Dai, et al.
Frontiers in Pharmacology (2021) Vol. 12
Open Access | Times Cited: 15
Tocilizumab (TCZ) Decreases Angiogenesis in Rheumatoid Arthritis Through Its Regulatory Effect on miR-146a-5p and EMMPRIN/CD147
Devy Zisman, Mirna Safieh, Elina Simanovich, et al.
Frontiers in Immunology (2021) Vol. 12
Open Access | Times Cited: 15
Tocilizumab attenuates acute lung injury in rats with sepsis by regulating S100A12/NLRP3.
Jingfa Zhu, Xinyu Lin, Cairong Yan, et al.
PubMed (2023) Vol. 15, Iss. 1, pp. 99-113
Closed Access | Times Cited: 5
TP0586532, a non-hydroxamate LpxC inhibitor, reduces LPS release and IL-6 production both in vitro and in vivo
Kiyoko Fujita, Iichiro Takata, Ippei Yoshida, et al.
The Journal of Antibiotics (2022) Vol. 75, Iss. 3, pp. 136-145
Open Access | Times Cited: 9
Expression of FoxO3a in sepsis mice and its association with lymphocyte apoptosis
Ya Wen, Yan Li, Jinli Guo, et al.
Cellular and Molecular Biology (2024) Vol. 70, Iss. 5, pp. 253-257
Open Access | Times Cited: 1
Antiinflammatory effects of adalimumab, tocilizumab, and steroid on lipopolysaccharide-induced lung injury
Nurhan Sarıoğlu, Fatma Bahar Sunay, Arzu YAY, et al.
TURKISH JOURNAL OF MEDICAL SCIENCES (2021) Vol. 51, Iss. 5, pp. 2741-2751
Open Access | Times Cited: 12
Tocilizumab for severe COVID‐19 pneumonia: Case series of 5 Australian patients
Timothy A. West, Sameer Malik, Anastasios Nalpantidis, et al.
International Journal of Rheumatic Diseases (2020) Vol. 23, Iss. 8, pp. 1030-1039
Open Access | Times Cited: 11
TOCIVID-19 - A multicenter study on the efficacy and tolerability of tocilizumab in the treatment of patients with COVID-19 pneumonia. Study protocol
Maria Carmela Piccirillo, Paolo A. Ascierto, Luigi Atripaldi, et al.
Contemporary Clinical Trials (2020) Vol. 98, pp. 106165-106165
Open Access | Times Cited: 11
Heart Failure Relapses in Response to Acute Stresses – Role of Immunological and Inflammatory Pathways
Lisa Hasselbach, Johannes Weidner, Albrecht Elsässer, et al.
Frontiers in Cardiovascular Medicine (2022) Vol. 9
Open Access | Times Cited: 6
Blockade of mIL‐6R alleviated lipopolysaccharide‐induced systemic inflammatory response syndrome by suppressing NF‐κB‐mediated Ccl2 expression and inflammasome activation
Jimin Dai, Xueqin Zhang, Jia‐Jia Zhang, et al.
MedComm (2022) Vol. 3, Iss. 2
Open Access | Times Cited: 6
Effect of Celecoxib and Infliximab against Multiple Organ Damage Induced by Sepsis in Rats: A Comparative Study
Shaymaa Ramzy Senousy, Mahmoud El‐Daly, Ahmed R. N. Ibrahim, et al.
Biomedicines (2022) Vol. 10, Iss. 7, pp. 1613-1613
Open Access | Times Cited: 6
Protective effect of Secukinumab on severe sepsis model rats by neutralizing IL-17A to inhibit IKBα/NFκB inflammatory signal pathway
Xinsheng Wang, Xinxin Zhang, Li Sun, et al.
European journal of medical research (2022) Vol. 27, Iss. 1
Open Access | Times Cited: 6
Anti-inflammatory Effect of Low-Intensity Ultrasound in Septic Rats
Wentao Tang, Yi Xia, Juan Deng, et al.
Ultrasound in Medicine & Biology (2023) Vol. 49, Iss. 7, pp. 1602-1610
Closed Access | Times Cited: 3
Tocilizumab is effective in preventing ovarian injury induced by ischemia- reperfusion in rats
Kemine Uzel, И. В. Лахно, Can Türkler, et al.
Anais da Academia Brasileira de Ciências (2023) Vol. 95, Iss. 1
Open Access | Times Cited: 3
Casein Kinase 2 Alpha Inhibition Protects against Sepsis-Induced Acute Kidney Injury
Jeung‐Hyun Koo, Hwang Chan Yu, Seonhwa Nam, et al.
International Journal of Molecular Sciences (2023) Vol. 24, Iss. 12, pp. 9783-9783
Open Access | Times Cited: 3
Propofol Attenuates Hypoxia/Reoxygenation-Induced Apoptosis and Autophagy in HK-2 Cells by Inhibiting JNK Activation
Huaxin Wang, Xuan Peng, Yayi Huang, et al.
Yonsei Medical Journal (2019) Vol. 60, Iss. 12, pp. 1195-1195
Open Access | Times Cited: 8
Mesenchymal stem cells microvesicles versus granulocytes colony stimulating factor efficacy in ameliorating septic induced acute renal cortical injury in adult male albino rats (Histological and Immunohistochemical Study)
Zeinab M. Alazouny, Nabila M Alghonamy, Samar R. Mohamed, et al.
Ultrastructural Pathology (2022) Vol. 46, Iss. 2, pp. 164-187
Closed Access | Times Cited: 5
Acute kidney injury in COVID 19 – an update on pathophysiology and management modalities
Manoj Khokhar, Purvi Purohit, Dipayan Roy, et al.
Archives of Physiology and Biochemistry (2020) Vol. 129, Iss. 3, pp. 626-639
Closed Access | Times Cited: 7
Natural products for treating cytokine storm–related diseases: Therapeutic effects and mechanisms
Mei Liu, Wang Qing, Wan-Ai Xu, et al.
Biomedicine & Pharmacotherapy (2023) Vol. 167, pp. 115555-115555
Open Access | Times Cited: 2
Amelioration of Sepsis-Induced Liver and Lung Injury by a Superoxide Dismutase Mimetic; Role of TNF-α and Caspase-3
Al‐Shaimaa F. Ahmed, Asmaa M. A. Bayoumi, Heba M. Eltahir, et al.
Journal of advanced Biomedical and Pharmaceutical Sciences (2019) Vol. 3, Iss. 1, pp. 31-39
Open Access | Times Cited: 6
XueFu ZhuYu Decoction Alleviates Cardiopulmonary Bypass-Induced NLRP3 Inflammasome-Dependent Pyroptosis by Inhibiting IkB-α/NF-κB Pathway in Acute Lung Injury Rats
Hui Li, Wenlei Zhang, Qiaoqin Lou, et al.
Evidence-based Complementary and Alternative Medicine (2022) Vol. 2022, pp. 1-15
Open Access | Times Cited: 4
Effect of Genetically Engineered Drugs on Aseptic Femoral Head Necrosis in Rats
N. А. Shabaldin, А. V. Sinitskaya, Л. Н. Игишева, et al.
Journal of Evolutionary Biochemistry and Physiology (2024) Vol. 60, Iss. 1, pp. 342-354
Closed Access

Scroll to top